Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corneal allograft rejection.

M H Friedlander1

  • 1Division of Ophthalmology, Scripps Clinic and Research Foundation, La Jolla, CA 92037.

Refractive & Corneal Surgery
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Corneal transplant rejection is a major hurdle, especially in vascularized cases. Matching human leukocyte antigen (HLA) and exploring new immunotherapies can improve corneal graft survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of response after laparoscopic splenectomy for immune thrombocytopenic purpura.

Surgical endoscopy·2001
Same author

Intraabdominal abscess rate after laparoscopic appendectomy.

American journal of surgery·2001
Same author

Use of fibrin sealant for prosthetic mesh fixation in laparoscopic extraperitoneal inguinal hernia repair.

Annals of surgery·2001
Same author

Laparoscopic repair of chronic intrathoracic gastric volvulus.

Surgery·2000
Same author

Reoperations after myopic laser in situ keratomileusis.

Journal of cataract and refractive surgery·2000
Same author

Mild form of Maroteaux-Lamy syndrome: corneal histopathology and ultrastructure.

Cornea·1998
Same journal

American Society for Cataract and Refractive Surgery. Summer symposium on refractive surgery. August 26-29, 1993 Los Angeles, Calif.

Refractive & corneal surgery·1993
Same journal

European Society of Cataract and Refractive Surgeons. 11th annual conference. August 29-September 2, 1993 Innsbruck, Austria.

Refractive & corneal surgery·1993
Same journal

International Society of Refractive Keratoplasty. 1993 Mid-Summer Symposium July 23-25, 1993. Minneapolis, Minn.

Refractive & corneal surgery·1993
Same journal

Opinions on mini-radial keratotomy.

Refractive & corneal surgery·1993
Same journal

Residual myopia after radial keratotomy successfully treated with Baikoff ZB5M IOLs.

Refractive & corneal surgery·1993
Same journal

Time-delayed, two-step excimer laser photorefractive keratectomy to correct high myopia.

Refractive & corneal surgery·1993
See all related articles

Area of Science:

  • Ophthalmology
  • Immunology
  • Transplantation Biology

Background:

  • Corneal allograft rejection is the primary cause of graft failure in corneal transplantation.
  • Cellular immunity significantly contributes to graft failure, particularly in vascularized corneas where failure rates can reach 60%.
  • Non-inflammatory and dystrophic corneal conditions generally have favorable outcomes.

Purpose of the Study:

  • To review the immunologic mechanisms underlying corneal allograft rejection.
  • To explore the role of the human leukocyte antigen (HLA) system in corneal transplantation success.
  • To discuss strategies for reducing graft-host disparity and improving corneal transplant survival.

Main Methods:

  • Review of existing literature on corneal allograft rejection and HLA matching.

Related Experiment Videos

  • Analysis of immunologic factors implicated in graft failure.
  • Discussion of potential therapeutic strategies.

    • Main Results:

    • Cellular immunity is a key factor in corneal graft failure.
    • Understanding HLA antigen distribution in the cornea is crucial.
    • Tissue typing and matching HLA antigens are believed to enhance success rates.

    Conclusions:

    • Matching human leukocyte antigen (HLA) class I and II antigens is expected to improve corneal transplant success.
    • Strategies such as reducing antigen load, inhibiting clonal expansion, and employing novel immunotherapies are vital for better corneal graft survival.